Current development of acupuncture research in parkinson's disease

International Review of Neurobiology

Volumn 111, Issue , 2013, Pages 141-158

  Zeng, Bai Yun ^a   Salvage, Sarah ^a   Jenner, Peter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acupuncture; Brain imaging; Models; Molecular mechanism; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOPHILIN A; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR;

ACUPUNCTURE; APOPTOSIS; ARTICLE; BASAL GANGLION; DISEASE MODEL; DOPAMINERGIC NERVE CELL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MASS SPECTROMETRY; MEDICAL RESEARCH; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

ACUPUNCTURE; BRAIN IMAGING; MODELS; MOLECULAR MECHANISM; PARKINSON'S DISEASE;

ACUPUNCTURE THERAPY; BIOMEDICAL RESEARCH; BRAIN; HUMANS; PARKINSON DISEASE;

EID: 84887382110     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-411545-3.00007-9     Document Type: Chapter

References (88)

1. Ahlskog J.E., Muenster M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Movement Disorders 2001, 16(3):448-458.
2. Akiyama H., McGeer P.L. Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Research 1989, 489:247-253.
3. Aleyasin H., Rousseaux M.W., Marcogliese P.C., Hewitt S.J., Irrcher I., Joselin A.P., et al. DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(7):3186-3191.
4. Betarbet R., Sherer T.B., Greenamyre J.T. Animal models of Parkinson's disease. Bioessays 2002, 24(4):308-318.
5. Braak H., Ghebremedhin E., Rüb U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research 2004, 318:121-134.
6. Burdo J.R., Connor J.R. Brain iron uptake and homeostatic mechanisms: An overview. Biometals 2003, 16:63-75.
7. Chae Y., Lee H., Kim H., Kim C.H., Chang D.I., Kim K.M., et al. Parsing brain activity associated with acupuncture treatment in Parkinson's diseases. Movement Disorders 2009, 24(12):1794-1802.
8. Chaudhuri K.R., Odin P., Antonini A., Martinez-Martin P. Parkinson's disease: The non-motor issues. Parkinsonism and Related Disorders 2011, 17(10):717-723.
9. Chen Y.I., Ren J.Q., Kaptchuk T.J., Kwong K.K. Restoring cerebral dopamine homeostasis by electrical forepaw stimulation: An FMRI study. Synapse 2012, 66(4):331-339.
10. Chen Y.I., Ren J., Wang F.N., Xu H., Mandeville J.B., Kim Y., et al. Inhibition of stimulated dopamine release and hemodynamic response in the brain through electrical stimulation of rat forepaw. Neuroscience Letters 2008, 431(3):231-235.
11. Chen Y.I., Wang F.N., Nelson A.J., Xu H., Kim Y., Rosen B.R., et al. Electrical stimulation modulates the amphetamine-induced hemodynamic changes: An fMRI study to compare the effect of stimulating locations and frequencies on rats. Neuroscience Letters 2008, 444(2):117-121.
12. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature 1981, 289:537-542.
13. Cho S.Y., Shim S.R., Rhee H.Y., Park H.J., Jung W.S., Moon S.K., et al. Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson's disease. Parkinsonism and Related Disorders 2012, 18(8):948-952.
14. Choi Y.G., Park J.H., Lim S. Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model. Neuroscience Letters 2009, 450(2):92-96.
15. Choi Y.G., Yeo S., Hong Y.M., Kim S.H., Lim S. Changes of gene expression profiles in the cervical spinal cord by acupuncture in an MPTP-intoxicated mouse model: microarray analysis. Gene 2011, 481(1):7-16.
16. Choi Y.G., Yeo S., Hong Y.M., Lim S. Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis. Cell and Molecular Neurobiology 2011, 31(3):377-391.
17. Cristian A., Katz M., Cutrone E., Walker R.H. Evaluation of acupuncture in the treatment of Parkinson's disease: A double-blind pilot study. Movement Disorders 2005, 20:1185-1188.
18. Dauer W., Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003, 39(6):889-909.
19. Dhond R.P., Kettner N., Napadow V. Neuroimaging acupuncture effects in the human brain. Journal of Alternative and Complementary Medicine 2007, 13(6):603-616.
20. Duty S., Jenner P. Animal models of Parkinson's disease: A source of novel treatments and clues to the cause of the disease. British Journal of Pharmacology 2011, 164(4):1357-1391.
21. Eng M.L., Lyons K.E., Greene M.S., Pahwa R. Open-label trial regarding the use of acupuncture and yin tui na in Parkinson's disease outpatients: A pilot study on efficacy, tolerability, and quality of life. Journal of Alternative and Complementary Medicine 2006, 12:395-399.
22. Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Reviews. Genetics 2006, 7:606-619.
23. Ferry P., Johnson M., Wallis P. Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease. Postgraduate Medical Journal 2002, 78:612-614.
24. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996, 380:252-255.
25. Grunblatt E., Mandel S., Youdim M.B. Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP. Annals of the New York Academy of Sciences 2000, 899:262-273.
26. Halliday G.M., Del Tredici K., Braak H. Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease. Journal of Neural Transmission Supplement 2006, 70:99-103.
27. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: A target for neuroprotection?. Lancet Neurology 2009, 8(4):382-397.
28. Hong M.S., Park H.K., Yang J.S., Park H.J., Kim S.T., Kim S.N., et al. Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model. Neurology Research 2010, 32(Suppl. 1):74-78.
29. Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., Brooks D.J. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995, 118(Pt. 4):913-933.
30. Jankovic J. Parkinson's disease: Clinical features and diagnosis. Journal of Neurological Neurosurgery Psychiatry 2008, 79(4):368-376.
31. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:2173-2177.
32. Jenner P. Oxidative stress in Parkinson's disease. Annals of Neurology 2003, 53(Suppl. 3):S26-S36.
33. Jenner P., Dexter D.T., Sian J., Schapira A.H., Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Annals of Neurology 1992, 32(Suppl.):S82-S87.
34. Jeon S., Kim Y.J., Kim S.T., Moon W., Chae Y., Kang M., et al. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics 2008, 8(22):4822-4832.
35. Jeun S.S., Kim J.S., Kim B.S., Park S.D., Lim E.C., Choi G.S., et al. Acupuncture stimulation for motor cortex activities: A 3T fMRI study. American Journal of Chinese Medicine 2005, 33:573-578.
36. Jia J., Li B., Sun Z.L., Yu F., Wang X., Wang X.M. Electro-acupuncture stimulation acts on the basal ganglia output pathway to ameliorate motor impairment in Parkinsonian model rats. Behavioural Neuroscience 2010, 124(2):305-310.
37. Jia J., Sun Z.L., Li B., Pan Y.L., Wang H.M., Wang X., et al. Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats. Behavioural Brain Research 2009, 205:214-218.
38. Kang J.M., Park H.J., Choi Y.G., Choe I.H., Park J.H., et al. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Research 2007, 1131(1):211-219.
39. Kim S.N., Doo A.R., Park J.Y., Bae H., Chae Y., Shim I. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease. PLoS One 2011, 6(11):e27566.
40. Kim S.N., Kim S.T., Doo A.R., Park J.Y., Moon W. Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease. International Journal of Neuroscience 2011, 121(10):562-569.
41. Kim Y.K., Lim H.H., Song Y.K., Lee H.H., Lim S., et al. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats. Neuroscience Letters 2005, 384(1-2):133-138.
42. Kim S.T., Moon W., Chae Y., Kim Y.J., Lee H., Park H.J. The effect of electroacupuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum. Journal of Physiological Sciences 2010, 60(1):27-34.
43. Knaryan V.H., Samantaray S., Le Gal C., Ray S.K., Banik N.L. Tracking extranigral degeneration in animal models of Parkinson's disease: Quest for effective therapeutic strategies. Journal of Neurochemistry 2011, 118(3):326-338.
44. Lee S.H., Jahng G.H., Choe I.H., Choi C.B., Kim D.H., Kim H.Y. Neural pathway interference by retained acupuncture: A functional MRI study of a dog model of Parkinson's disease. CNS Neuroscience Therapy 2013, 19:585-595. 10.1111/cns.12108.
45. Liang X.B., Liu X.Y., Li F.Q., Luo Y., Lu J., Zhang W.M., et al. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Brain Research Molecular Brain Research 2002, 108(1-2):51-59.
46. Liang X.B., Luo Y., Liu X.Y., Lu J., Li F.Q., Wang Q., et al. Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB transected rats. Neuroreport 2003, 14(8):1177-1181.
47. Liberatore G.T., Jackson-Lewis V., Vukosavic S., et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nature Medicine 1999, 5:1403-1409.
48. Liu X.Y., Zhou H.F., Pan Y.L., Liang X.B., Niu D.B., et al. Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats. Experimental Neurology 2004, 189(1):189-196.
49. Mallol R., Barrós-Loscertales A., López M., Belloch V., Parcet M.A., Avila C. Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements. Brain Research 2007, 1147:265-271.
50. Mandel S., Maor G., Youdim M.B. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: Effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. Journal of Molecular Neuroscience 2004, 24:401-416.
51. Ogawa S., Tank D., Menon R., et al. Intrinsic signal changes accompanying sensory stimulation: Functional brain mapping with magnetic resonance imaging. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:5951-5955.
52. Owen A.M., Doyon J., Dagher A., Sadikot A., Evans A.C. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998, 121:949-965.
53. Park H.J., Lim S., Joo W.S., Yin C.S., Lee H.S., et al. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Experimental Neurology 2003, 180(1):93-98.
54. Pecci C., Rivas M.J., Moretti C.M., Raina G., Ramirez C.Z., et al. Use of complementary and alternative therapies in outpatients with Parkinson's disease in Argentina. Movement Disorders 2010, 25(13):2094-2098.
55. Perumal A.S., Gopal V.B., Tordzro W.K., Cooper T.B., Cadet J.L. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Research Bulletin 1992, 29:699-701.
56. Rabinstein A.A., Shulman L.M. Acupuncture in clinical neurology. The Neurologist 2003, 9:137-148.
57. Rajendran P.R., Thompson R.E., Reich S.G. The use of alternative therapies by patients with Parkinson's disease. Neurology 2001, 57:790-794.
58. Rascol O., Sabatini U., Fabre N., Brefel C., Loubinoux I., Celsis P., et al. The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 1997, 120(Pt 1):103-110.
59. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. Journal of Neurochemistry 1989, 52:515-520.
60. Robertson G.S., Robertson H.A. Evidence that l-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. Journal of Neuroscience 1989, 9:3326-3331.
61. Salin P., Manrique C., Forni C., Kerkerian-Le Goff L. High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. Journal of Neuroscience 2002, 22(12):5137-5148.
62. Schapira A.H., Jenner P. Etiology and pathogenesis of Parkinson's disease. Movement Disorders 2011, 26(6):1049-1055.
63. Segovia J., Garcia-Munoz M. Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervation. Neuropharmacology 1987, 26(9):1449-1451.
64. Shulman L.M., Wen X., Weiner W.J., Bateman D., Minagar A., et al. Acupuncture therapy for the symptoms of Parkinson's disease. Movement Disorders 2002, 17(4):799-802.
65. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Annals of Neurology 1994, 36:348-355.
66. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. Journal of Neural Transmission 1988, 74:199-205.
67. Soghomonian J.J., Chesselet M.F. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 1992, 11(2):124-133.
68. Stocchi F., Tagliati M., Olanow C.W. Treatment of levodopa-induced motor complications. Movement Disorders 2008, 23(Suppl. 3):S599-S612.
69. Su X., Maguire-Zeiss K.A., Giuliano R., Prifti L., Venkatesh K., Federo H.J. Synuclein activates microglia in a model of Parkinson's disease. Neurobiology Aging 2008, 29:1690-1701.
70. Sugama S., Cho B.P., Degiorgio L.A., Shimizu Y., Kim S.S., Kim Y.S., et al. Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat. Neuroscience 2003, 116:925-933.
71. Sulzer D. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends in Neuroscience 2007, 30(5):244-250.
72. Sun Z., Jia J., Gong X., Jia Y., Deng J., Wang X., Wang X. Inhibition of glutamate and acetylcholine release in behavioral improvement induced by electroacupuncture in parkinsonian rats. Neuroscience Letters 2012, 520(1):32-37.
73. Tan L.C., Lau P.N., Jamora R.D., Chan E.S. Use of complementary therapies in patients with Parkinson's disease in Singapore. Movement Disorders 2006, 21(1):86-89.
74. Tansey M.G., McCoy M.K., Frank-Cannon T.C. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Experimental Neurology 2007, 208:1-25.
75. Tseng J.L., Baetge E.E., Zurn A.D., Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. Journal of Neuroscience 1997, 17:325-333.
76. Wang J., Jiang H., Xie J.X. Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. Neurochemistry Research 2004, 29(12):2239-2243.
77. Wang H., Liang X., Wang X., Luo D., Jia J., Wang X. Electro-acupuncture stimulation improves spontaneous locomotor hyperactivity in MPTP intoxicated mice. PLoS One 2013, 8(5):64403. 10.1371/journal.pone.0064403.
78. Wang H., Pan Y., Xue B., Wang X., Zhao F., et al. The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease. PLoS One 2011, 6(5):e19790. 10.1371/journal.pone.0019790.
79. Winkler C., Bentlage C., Cenci M.A., Nikkhah G., Björklund A. Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model. Neuroscience 2003, 118(4):1063-1077.
80. Wolters E.C., Braak H. Parkinson's disease: Premotor clinico-pathological correlations. Journal of Neural Transmission Supplement 2006, 70:309-319.
81. Wu J.-N. A short history of acupuncture. Journal of Alternative and Complementary Medicine 1996, 2:19-21.
82. Wu D.C., Jackson-Lewis V., Vila M., et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. Journal of Neuroscience 2002, 22:1763-1771.
83. Wu T., Long X., Zang Y., Wang L., Hallett M., Li K., Chan P. Regional homogeneity changes in patients with Parkinson's disease. Human Brain Mapping 2009, 30(5):1502-1510.
84. Wu M.T., Sheen J.M., Chuang K.H., et al. Neuronal specificity of acupuncture response: A fMRI study with electroacupuncture. Neuroimage 2002, 16:1028-1037.
85. Yeo S., Choi Y.G., Hong Y.M., Lim S. Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of parkinsonism: Microarray analysis. Gene 2013, 515(2):329-338. 10.1016/j.gene.2012.12.002.
86. Yeo S., Lim S., Choe I.H., Choi Y.G., Chung K.C., et al. Acupuncture stimulation on GB34 activates neural responses associated with Parkinson's disease. CNS Neuroscience Therapy 2012, 18(9):781-790.
87. Yu Y.P., Ju W.P., Li Z.G., Wang D.Z., Wang Y.C., Xie A.M. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Research 2010, 1336:58-65.
88. Zhang W.T., Jin Z., Luo F., Zhang L., Zeng Y.W., Han J.S. Evidence from brain imaging with fMRI supporting functional specificity of acupoints in humans. Neuroscience Letters 2004, 354:50-53.